News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EnVivo Pharmaceuticals, Inc. Names Christopher L. Burnley Chief Business Officer


4/19/2012 10:06:00 AM

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced that Christopher L. Burnley has been appointed chief business officer. Mr. Burnley brings 25 years of broad industry experience focused on business operations, finance, strategy development and corporate development. In his new role, he will be responsible for shaping EnVivo’s long-term corporate strategy and executing its business development plans.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES